Skeletal Damage and Cross-correction after ex-vivo Gene Therapy in Mucopolysaccharidosis type I Hurler

被引:0
|
作者
Santi, Ludovica [1 ]
Crippa, Stefania [1 ]
Capo, Valentina [1 ]
Penna, Sara [1 ]
Savoia, Evelyn [1 ]
De Ponti, Giada [1 ]
Alberti, Gaia [1 ]
Berti, Margherita [1 ]
Ceriotti, Selene [1 ]
Consiglieri, Giulia [2 ]
Tucci, Francesca [2 ]
Riminucci, Mara [3 ]
Corsi, Alessandro [3 ]
Barbero, Andrea [4 ]
Martin, Ivan [4 ]
Sanvito, Francesca [5 ]
Norata, Rossana [5 ]
Rocchi, Martina [5 ]
Bolamperti, Simona [6 ]
Villa, Isabella [6 ]
Aiuti, Alessandro [1 ]
Villa, Anna [1 ]
Bernardo, Maria Ester [1 ]
机构
[1] San Raffaele Telethon Inst Gene Therapy, Milan, Italy
[2] IRCCS San Raffaele Sci Inst, Pediatr Immunohematol & Bone Marrow Transplantat, Milan, Italy
[3] Sapienza Univ, Dept Mol Med, Rome, Italy
[4] Univ Basel Hosp, Tissue Engn Dept Biomed, Basel, Switzerland
[5] IRCCS San Raffaele Sci Inst, GLP San Raffaele Telethon Inst Gene Therapy, Milan, Italy
[6] IRCCS San Raffaele Sci Inst, Osteoporosis & Bone & Mineral Metab Unit, Milan, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
FRI-166
引用
收藏
页码:30 / 31
页数:2
相关论文
共 50 条
  • [31] Ex-Vivo Autologous Stem Cell Gene Therapy Clinical Trial for Mucopolysaccharidosis Type IIIA: Trial in Progress-NCT04201405
    Kinsella, Jane L.
    Wynn, Robert F.
    Bigger, Brian
    Thrasher, Adrian J.
    Booth, Claire
    Buckland, Karen
    Izotova, Natalia
    Rust, Stewart
    Weisberg, Daniel
    Church, Heather J.
    Brammeier, Kathryn L.
    Tylee, Karen L.
    Jones, Ceri
    Lee, Helena
    Ford, Laura
    Sadegholnejat, Atusa
    Ellison, Stuart
    Jones, Simon A.
    BLOOD, 2020, 136
  • [32] INTERIM ANALYSIS ON NEUROLOGICAL OUTCOMES IN HURLER SYNDROME PATIENTS TREATED WITH EX-VIVO HAEMATOPOIETIC STEM CELL GENE THERAPY
    Consiglieri, Giulia
    Fumagalli, Francesca
    Tucci, Francesca
    Filisetti, Chiara
    Cossutta, Matilde
    Scarparo, Stefano
    Sarzana, Marina
    Puricelli, Cristina
    Ciotti, Francesca
    Barbera, Maurizio
    Darin, Silvia
    Parini, Rossella
    Baldoli, Cristina
    Gentner, Bernhard
    Aiuti, Alessandro
    Bernardo, Maria Ester
    BONE MARROW TRANSPLANTATION, 2024, 59 : 67 - 68
  • [33] Clinical trial design for HMI-203 investigational gene therapy for mucopolysaccharidosis type II (MPS II) informed by cross-correction potential and KOL input
    Gingras, Jacinthe
    Haroldson, Jeff
    Smith, Laura J.
    Patel, Kruti
    Salstrom, Jen
    Jordan, Julie
    Cohn, Gabriel M.
    Francone, Omar
    Seymour, Albert
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S46 - S46
  • [34] An innovative platform approach for the preclinical development of ex-vivo gene therapy for lysosomal storage disorders with skeletal
    Crippa, S.
    Scala, S.
    Alberti, G.
    Forni, C.
    Berti, M.
    Quaranta, P.
    Santi, L.
    De Ponti, G.
    Jofra-Hernandez, R.
    Basso-Ricci, L.
    Rilievo, A. A.
    Visigalli, I.
    Cecere, F.
    Zonari, E.
    Consiglieri, G.
    Tucci, F.
    Cossutta, M.
    Albertini, P.
    Parini, R.
    Gentner, B.
    Bernardo, M. E.
    Aiuti, A.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A246 - A246
  • [35] Liver-directed gene therapy corrects neurologic disease in a murine model of mucopolysaccharidosis type I-Hurler
    Jin, Xiu
    Su, Jing
    Zhao, Qinyu
    Li, Ruiting
    Xiao, Jianlu
    Zhong, Xiaomei
    Song, Li
    Liu, Yi
    She, Kaiqin
    Deng, Hongxin
    Wei, Yuquan
    Yang, Yang
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2022, 25 : 370 - 381
  • [36] Dissecting bone remodelling mechanisms and hematopoietic stem cell gene therapy impact in Mucopolysaccharidosis type I Hurler bone defects
    Santi, L.
    Penna, S.
    Crippa, S.
    Capo, V.
    De Ponti, G.
    Berti, M.
    Mancino, M.
    Tucci, F.
    Riminucci, M.
    Corsi, A.
    Serafini, M.
    Klein, T.
    Lopa, S.
    Martin, I.
    Moretti, M.
    Gentner, B.
    Aiuti, A.
    Villa, A.
    Bernardo, M. E.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A77 - A77
  • [37] Dissecting Bone Remodelling Mechanisms and Hematopoietic Stem Cell Gene Therapy Impact in Mucopolysaccharidosis Type I Hurler Bone Defects
    Santi, Ludovica
    Penna, Sara
    Crippa, Stefania
    Capo, Valentina
    De Ponti, Giada
    Berti, Margherita
    Mancino, Marilena
    Tucci, Francesca
    Riminucci, Mara
    Corsi, Alessandro
    Serafini, Marta
    Klein, Thibaut
    Martin, Ivan
    Gentner, Bernhard
    Aiuti, Alessandro
    Villa, Anna
    Bernardo, Maria Ester
    MOLECULAR THERAPY, 2021, 29 (04) : 295 - 296
  • [38] Ex vivo gene therapy improves the accumulation of glycosaminoglycans in brain from murine model of mucopolysaccharidosis type II
    Wakabayashi, Taichi
    Shimada, Yohta
    Higuchi, Takashi
    Kobayashi, Hiroshi
    Ida, Hiroyuki
    Ohashi, Toya
    GLYCOBIOLOGY, 2014, 24 (11) : 1214 - 1214
  • [39] Mucopolysaccharidosis Type I Ex Vivo Gene Therapy Based on MLV-Mesenchymal Stem Cell Transduction: Is There a Way To Be Attenuated When Older?
    Silva, Flavia H.
    Pereira, Vanessa F.
    Yasumura, Eduardo
    Tenorio, Ligia Z.
    Carvalho, Leonardo P.
    Lisboa, Bianca C.
    Calegare, Bruno F.
    Brandao, Leticia D.
    D'Almeida, Vania
    Filippo, Thais R.
    Porcionatto, Marimelia
    Toma, Leny
    Nader, Helena B.
    Camassola, Melissa
    Nardi, Nance B.
    Han, Sang W.
    MOLECULAR THERAPY, 2009, 17 : S345 - S345
  • [40] Hematopoietic stem cell gene therapy for mucopolysaccharidosis type I-Hurler syndrome (OTL-203): Interim skeletal, neurological and systemic outcomes from a phase I/II study
    Bernardo, Maria Ester M.
    Tucci, Francesca
    Consiglieri, Giulia
    Oficialdegui, Maria Luz Uria
    Fumagalli, Francesca
    De Pellegrin, Maurizio
    Cossutta, Matilde
    Filisetti, Chiara
    Manitto, Maria Pia
    Butera, Carla
    Dane, Giulia
    Camesasca, Chiara
    Parini, Rossella
    Riera, Mireia Del Toro
    de Heredia, Cristina Diaz
    Aiuti, Alessandro
    MOLECULAR GENETICS AND METABOLISM, 2025, 144 (02) : 10 - 11